Back

Impact of ablation modality on alternative efficacy endpoint definition of pulmonary vein isolation for atrial fibrillation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Catheter ablation in atrial fibrillation: new technologies Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Fabian Jordan

Cardiovascular Research Institute Basel, Basel (Switzerland)

7 More presentations in this session

Presentation thumbnail
Long-term clinical effectiveness of pulsed field ablation in elderly patients with atrial fibrillation: sub-analysis of the global FARADISE registry
Professor A. Dello Russo (Ancona, IT)
Abstract Slides Video
Presentation thumbnail
Sex differences in long-term clinical effectiveness after pulsed field ablation to treat atrial fibrillation. Sub-analysis of the global FARADISE registry
Doctor J. Vijgen (Hasselt, BE)
Abstract Slides
Presentation thumbnail
One-year outcome using a size-adjustable cryoballoon in patients with atrial fibrillation
Mr Y. Hayashi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Procedural characteristics of very high-power short-duration compared to ablation index-guided ablation for pulmonary vein isolation in atrial fibrillation patients
Ms N. Van Pouderoijen (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Significance of pulmonary vein reconnections and extra-pulmonary vein procedures in repeated atrial fibrillation ablation
Doctor S. Kawai (Iizuka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation in atrial fibrillation: new technologies

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Arrhythmia recurrence after pulmonary vein isolation using radiofrequency ablation vs. pulsed field ablation
thumbnail
Congress Presentation
Long-term outcomes of patients treated with pulsed field ablation under the first-in-human clinical trials with prospective invasive remap
thumbnail
Congress Session
Atrial fibrillation: ablation 3

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources